Crescent Biopharma (CBIO) Accounts Payables (2013 - 2026)
Crescent Biopharma (CBIO) posted Accounts Payables of $2.54 million for Q2 2026, down 51.1% from $5.2 million a year earlier but up 113.6% from the prior quarter.
Crescent Biopharma (CBIO) Accounts Payables (2013 - 2026) Analysis & Trends
At the end of FY2025, Crescent Biopharma's Accounts Payables came in at $10 million.
- Annual Accounts Payables shows a five-year compound annual growth rate of 36.8% (FY2020 to FY2025).
- In prior years, Crescent Biopharma's Accounts Payables was $329,304 in FY2024 (-62.1%), $868,115 in FY2023 (-10.5%), $970,191 in FY2022 (-54.0%) and $2.11 million in FY2021 (+0.8%).
- Quarterly Accounts Payables has run from a low of $104,671 in Q1 2025 to a high of $10 million in Q4 2025 over five years.
- On a year-over-year basis, Accounts Payables increased in three of the last six quarters, with growth averaging 217.8%.
- The strongest year-over-year quarter for Accounts Payables in the past five years was Q3 2025, with growth of 982.9%; the weakest was Q1 2025, with a decline of 86.1%.
- According to Business Quant data, Accounts Payables for the three prior quarters was $1.19 million (Q1 2026), $10 million (Q4 2025) and $6.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 9.22 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 3.83 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.58 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Crescent Biopharma | 409.68 Mn | -297.61 Mn | - | 2.54 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.54 Mn |
| Mar 31, 2026 | 1.19 Mn |
| Dec 31, 2025 | 10.00 Mn |
| Sep 30, 2025 | 6.30 Mn |
| Jun 30, 2025 | 5.20 Mn |
| Mar 31, 2025 | 104,671.00 |
| Dec 31, 2024 | 329,304.00 |
| Sep 30, 2024 | 581,794.00 |
| Jun 30, 2024 | 950,763.00 |
| Mar 31, 2024 | 755,534.00 |
| Dec 31, 2023 | 868,115.00 |
| Sep 30, 2023 | 329,885.00 |
| Jun 30, 2023 | 241,487.00 |
| Mar 31, 2023 | 480,151.00 |
| Dec 31, 2022 | 970,191.00 |
| Sep 30, 2022 | 852,125.00 |
| Jun 30, 2022 | 1.27 Mn |
| Mar 31, 2022 | 2.28 Mn |
| Dec 31, 2021 | 2.11 Mn |
| Sep 30, 2021 | 1.39 Mn |
Crescent Biopharma Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=CBIO&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "CBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=CBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();